GACM
PFE icon

Green Arrow Capital Management’s Pfizer PFE Stock Holding History

Green Arrow Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-105,400
Closed -$3M – 237
2014
Q1 		$3.21M Buy
+105,400
New +$3.14M 0.27% 123
2013
Q4 		– Sell
-52,700
Closed -$1.44M – 305
2013
Q3 		$1.44M Buy
+52,700
New +$1.43M 0.11% 192

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Green Arrow Capital Management's PFE Position: Q2 2014 in Review

Green Arrow Capital Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 105,400 shares — an estimated $3M sold.

Green Arrow Capital Management first reported a position in PFE in Q3 2013 and held it in 2 quarters. The position peaked at $3.21M in Q1 2014. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Green Arrow Capital Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 105,400 Pfizer shares in Q2 2014, an estimated $3M.
  • Green Arrow Capital Management first reported a position in Pfizer in Q3 2013 and held it in 2 quarters.
  • Green Arrow Capital Management's Pfizer position peaked at $3.21M in Q1 2014.
  • 1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Green Arrow Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.